Amantadine is commonly used for Parkinsonism. However amantadine can induce adverse corneal reaction. Here we report a patient with primary progressive freezing of gait who had severe corneal edema associated with amantadine, which was reversible after discontinuation of the amantadine. This report alerts neurologists for this reversible but potentially critical corneal edema in patients with Parkinsonism who are receiving amantadine.

Citations

Citations to this article as recorded by  

• Amantadine-induced corneal edema – A reversible cause of visual blurring in Parkinson’s disease
  Jacky Ganguly, Soumava Mukherjee, Nilam Singh, Hrishikesh Kumar
  Annals of Movement Disorders.2025; 8(1): 91.     CrossRef
• Neural dysfunction, inflammatory disorder, and metabolic interference feature in amantadine-related adverse drug events: a perspective from FAERS and network toxicology
  Jing Yang, Yang Tian, Yue Luo, Hong-Wei Luo, Yi-Ling Wang, Bin Chen, Xing Jiang, Gu-Yu Liu, Ying-Qiu Wu, Zhi Liu, Rui-Ling Ye, Chao Wang, Xin-Lan Guan
  Expert Opinion on Drug Safety.2025; : 1.     CrossRef
• Botulinum Toxin Effects on Freezing of Gait in Parkinson’s Disease: A Systematic Review
  Nicola Tambasco, Pasquale Nigro, Alessandro Mechelli, Michele Duranti, Lucilla Parnetti
  Toxins.2024; 16(11): 474.     CrossRef
• Amantadine-induced corneal edema: A case and literature review
  Antony Raharja, Wessam Mina, Zahra Ashena
  American Journal of Ophthalmology Case Reports.2023; 32: 101881.     CrossRef
• Experience of diagnosis and managements for patients with primary progressive freezing of gait
  Li-Li Zhang, Ya-Jie Zhao, Liang Zhang, Xiao-Ping Wang
  Journal of Neurorestoratology.2022; : 100039.     CrossRef
• Toxicity of amantadine hydrochloride on cultured bovine cornea endothelial cells
  Po-Yen Lee, Yu-Hung Lai, Po-Len Liu, Ching-Chih Liu, Chia-Cheng Su, Fang-Yen Chiu, Wei-Chung Cheng, Shiuh-Liang Hsu, Kai-Chun Cheng, Li-Yi Chiu, Tzu-En Kao, Chia-Ching Lin, Yo-Chen Chang, Shu-Chi Wang, Chia-Yang Li
  Scientific Reports.2021;[Epub]     CrossRef
• Efficacy and safety of amantadine for the treatment of l-DOPA-induced dyskinesia
  Santiago Perez-Lloret, Olivier Rascol
  Journal of Neural Transmission.2018; 125(8): 1237.     CrossRef
• Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked
  Merel S. Ekker, Sabine Janssen, Klaus Seppi, Werner Poewe, Nienke M. de Vries, Thomas Theelen, Jorik Nonnekes, Bastiaan R. Bloem
  Parkinsonism & Related Disorders.2017; 40: 1.     CrossRef
• Parkinson’s disease between internal medicine and neurology
  Ilona Csoti, Wolfgang H. Jost, Heinz Reichmann
  Journal of Neural Transmission.2016; 123(1): 3.     CrossRef
• Amantadine Use as a Risk Factor for Corneal Edema: A Nationwide Cohort Study in Taiwan
  Po Yen Lee, Hung Pin Tu, Chang Ping Lin, Cheng Hsien Chang, Kai Chun Cheng, Chia Ching Lin, Shiuh Liang Hsu
  American Journal of Ophthalmology.2016; 171: 122.     CrossRef